作者:Ocuphire Pharma(RNN)
发布于: | 公告 | 转发:0 | 回复:0 | 喜欢:0 |
$REXAHN PHARMACEUTICALS INC(RNN)$ 8-K - Current report Filed: 2017-06-07 AccNo: 0001140361-17-024258 Size: 386 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接